Resilience Training for High Risk of Psychosis
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if Resilience Training can assist college students at higher risk of developing serious mental health issues. The program spans four weeks, teaching skills such as mindfulness and self-compassion. Another group will engage in Life Skills Training, which focuses on practical skills like financial literacy and health. The trial is designed for first or second-year college students who have experienced some psychotic episodes. Participants should not currently receive psychological treatment or use certain medications. As an unphased trial, this study provides a unique opportunity for students to acquire valuable skills that could enhance their mental well-being.
Will I have to stop taking my current medications?
The trial requires that participants are not currently using psychotropic medications (drugs that affect mood, perception, or behavior) other than stimulants. If you are taking such medications, you would need to stop before joining the trial.
What prior data suggests that Resilience Training is safe for college students at high risk of psychosis?
Research shows that Resilience Training is generally easy for people to handle. Studies on resilience examine how certain protective factors help individuals manage risks, such as developing serious mental health issues. This training teaches skills like mindfulness (paying attention to the present moment), self-compassion (being kind to oneself), and mentalization (understanding one's own and others' thoughts and feelings). These skills are not known to cause harm.
Similar programs have reported no major negative effects. Participants often find these skills useful for managing stress and improving mental well-being. Although hard data is limited, the nature of the training suggests it is safe for participants.12345Why are researchers excited about this trial?
Researchers are excited about Resilience Training (RT) for individuals at high risk of psychosis because it takes a fresh approach by focusing on mental skills like mindfulness, self-compassion, and mentalization. Unlike traditional treatments that often rely on medication or cognitive therapy, RT empowers individuals through a 4-week program of interactive sessions designed to build personal resilience. This method aims to enhance mental well-being by teaching participants to better manage their thoughts and emotions, potentially offering a proactive way to reduce the risk of psychosis.
What evidence suggests that Resilience Training could be effective for reducing the risk of serious mental illness?
Research shows that Resilience Training (RT), a treatment in this trial, can help reduce mental health symptoms. Studies have found that RT, which includes mindfulness and self-compassion exercises, improves resilience and reduces symptoms of mental health issues. Participants in RT programs reported lasting improvements in their mental well-being, even after the training ended. This trial will compare RT with Life Skills Training (LST), another treatment arm, to determine their effectiveness in helping college students at risk for serious mental health problems by strengthening their mental resilience.23567
Are You a Good Fit for This Trial?
This trial is for college students who may be at high risk of developing serious mental illnesses, such as psychosis or mood and anxiety disorders. Participants should not yet have a diagnosed severe mental illness but might experience early signs like unusual thoughts.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo a 4-week program of weekly 90-minute sessions, either Resilience Training or Life Skills Training
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Resilience Training
Find a Clinic Near You
Who Is Running the Clinical Trial?
Massachusetts General Hospital
Lead Sponsor